<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-119452</identifier>
<setSpec>0213-4853</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Guidelines for the treatment of acute ischaemic stroke</dc:title>
<dc:description xml:lang="en">Introduction: Update of Acute Ischaemic Stroke Treatment Guidelines of the Spanish Neurological Society based on a critical review of the literature. Recommendations are made based on levels of evidence from published data and studies. Development: Organized systems of care should be implemented to ensure access to the optimal management of all acute stroke patients in stroke units. Standard of care should include treatment of blood pressure (should only be treated if values are over 185/105 mmHg), treatment of hyperglycaemia over 155 mg/dl, and treatment of body temperature with antipyretic drugs if it rises above 37.5 &amp;#9702;C. Neurological and systemic complications must be prevented and promptly treated. Decompressive hemicraniectomy should be considered in cases of malignant cerebral oedema. Intravenous thrombolysis with rtPA should be administered within 4.5 hours from symptom onset, except when there are contraindications. Intra-arterial pharmacological thrombolysis can be considered within 6 hours, and mechanical thrombectomy within 8 hours from onset, for anterior circulation strokes, while a wider window of opportunity up to 12-24 hours is feasible for posterior strokes. There is not enough evidence to recommend routine use of the so called neuroprotective drugs. Anticoagulation should be administered to patients with cerebral vein thrombosis. Rehabilitation should be started as early as possible. Conclusion: Treatment of acute ischaemic stroke includes management of patients in stroke units. Systemic thrombolysis should be considered within 4.5 hours from symptom onset. Intraarterial approaches with a wider window of opportunity can be an option in certain cases. Protective and restorative therapies are being investigated  (AU)</dc:description>
<dc:creator>García Pastor, A</dc:creator>
<dc:creator>Gilo, F</dc:creator>
<dc:creator>Simal, P</dc:creator>
<dc:creator>Alonso de leciñana, M</dc:creator>
<dc:creator>Martí Fábregas, J</dc:creator>
<dc:creator>Purroy, F</dc:creator>
<dc:creator>Ribó, M</dc:creator>
<dc:creator>Dávalos, A</dc:creator>
<dc:creator>Masjuan, J</dc:creator>
<dc:creator>Lago, A</dc:creator>
<dc:creator>Fuentes, B</dc:creator>
<dc:creator>Díez Tejedor, E</dc:creator>
<dc:creator>López Fernández, J. C</dc:creator>
<dc:creator>Irimia, P</dc:creator>
<dc:creator>Caniego, J. L</dc:creator>
<dc:creator>Gil Núñez, A</dc:creator>
<dc:creator>Molina, C</dc:creator>
<dc:creator>Maestre, J</dc:creator>
<dc:creator>Serena, J</dc:creator>
<dc:creator>Vivancos, J</dc:creator>
<dc:creator>Castillo, J</dc:creator>
<dc:creator>Rubio, F</dc:creator>
<dc:creator>Tejada, J</dc:creator>
<dc:creator>Calleja, S</dc:creator>
<dc:creator>Freijo, M</dc:creator>
<dc:creator>Nombela, F</dc:creator>
<dc:creator>Álvarez Sabin, J</dc:creator>
<dc:creator>Egido, J. A</dc:creator>
<dc:creator>Díaz Otero, F</dc:creator>
<dc:creator>Roquer, J</dc:creator>
<dc:creator>Morales, A</dc:creator>
<dc:creator>Arenillas, J</dc:creator>
<dc:creator>Segura, T</dc:creator>
<dc:creator>Rodríguez Yañez, M</dc:creator>
<dc:creator>Martínez Vila, E</dc:creator>
<dc:creator>Martínez Sánchez, P</dc:creator>
<dc:creator>Gállego, J</dc:creator>
<dc:creator>Castellanos, M</dc:creator>
<dc:creator>Casado, I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Actualización de la guía para el tratamiento del infarto cerebral agudo de la Sociedad Espa&#152;nola de Neurología basada en la revisión y análisis de la bibliografía existente sobre el tema. Se establecen recomendaciones en base al nivel de evidencia que ofrecen los estudios revisados. Desarrollo: Los sistemas de asistencia urgente extrahospitalaria se organizarán para asegurar la atención especializada de los pacientes y el ingreso en unidades de ictus (UI). Deben aplicarse cuidados generales para mantener la homeostasis (tratar la tensión arterial sistólica &gt; 185 mmHg o diastólica &gt; 105 mmHg, evitar hiperglucemia &gt; 155 mg/dl y controlar la temperatura,  tratando con antitérmicos cifras &gt; 37,5 &amp;#9702;C), y prevenir y tratar las complicaciones. La craniectomía descompresiva debe ser considerada en casos seleccionados de edema cerebral maligno. La trombólisis intravenosa con rtPA se administrará en las primeras 4,5 horas en pacientes sin contraindicación. La trombólisis intraarterial farmacológica puede indicarse en las primeras 6 horas de evolución y la trombectomía mecánica hasta las 8 horas. En el territorio posterior la ventana puede ampliarse hasta 12-24 horas. No hay evidencias para recomendar el uso rutinario de los fármacos denominados neuroprotectores. Se recomienda la anticoagulación en pacientes con trombosis de senos venosos. Se aconseja el inicio precoz de rehabilitación. Conclusiones: El tratamiento del infarto cerebral se basa en la atención especializada en UI, la aplicación urgente de cuidados generales y el tratamiento trombolítico intravenoso en las primeras 4,5 horas. La recanalización intraarterial farmacológica o mecánica pueden ser útiles en casos seleccionados. Terapias de protección y reparación cerebral están en desarrollo (AU)</dc:description>
<dc:source>Neurologia;29(2): 102-122, mar. 2014. tab</dc:source>
<dc:identifier>ibc-119452</dc:identifier>
<dc:title xml:lang="es">Guía para el tratamiento del infarto cerebral agudo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2586^s22057</dc:subject>
<dc:subject>^d24892^s22074</dc:subject>
<dc:subject>^d53699^s22074</dc:subject>
<dc:subject>^d32116^s22073</dc:subject>
<dc:subject>^d34258^s22057</dc:subject>
<dc:subject>^d19291</dc:subject>
<dc:subject>^d6913^s22049</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2583^s22057</dc:subject>
<dc:type>article</dc:type>
<dc:date>201403</dc:date>
</metadata>
</record>
</ibecs-document>
